Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-06
2008-05-06
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07368582
ABSTRACT:
Compounds corresponding to formula I:in which R1, R2, R3, R4, R5and R6have the meanings given in the description; a process for the preparation of these compounds; intermediate products used to prepare such compounds, and pharmaceutical compositions containing such compounds.
REFERENCES:
patent: 5191092 (1993-03-01), Niewöhner et al.
patent: 5637739 (1997-06-01), Jacobsen et al.
patent: 5663393 (1997-09-01), Jacobsen et al.
patent: 5811448 (1998-09-01), Englert et al.
patent: 5955607 (1999-09-01), Brendel et al.
patent: 6071953 (2000-06-01), Lang et al.
patent: 6150356 (2000-11-01), Lloyd et al.
patent: 6177449 (2001-01-01), Brendel et al.
patent: 6191164 (2001-02-01), Lang et al.
patent: 6221866 (2001-04-01), Brendel et al.
patent: 6511977 (2003-01-01), Lloyd et al.
patent: 2004/0058931 (2004-03-01), Lloyd et al.
patent: 2004/0067944 (2004-04-01), Lloyd et al.
patent: 0 425 946 (1991-08-01), None
patent: 0 807 629 (1997-11-01), None
patent: 0 860 440 (1998-08-01), None
patent: 0 905 131 (1999-03-01), None
patent: 0 906 911 (1999-04-01), None
patent: 2000-336085 (2000-12-01), None
patent: WO 91/14694 (1991-10-01), None
patent: WO 00/12077 (2000-03-01), None
patent: WO 00/14084 (2000-03-01), None
patent: WO 00/58300 (2000-10-01), None
patent: WO 01/00573 (2001-01-01), None
Gregory J. Amos et al., “Differences between outward currents of human atrial and subepicardial ventricular myocytes,” Journal of Physiology (1996), 491.1, pp. 31-50.
Christine Beeton et al., “Selective Blocking of Voltage-Gated K+Channels Improves Experimental Autoimmune Encephalomyelitis and Inhibits T Cell Activation1,” The Journal of Immunology, pp. 936-944.
Torill Berg, “Analysis of the pressor response to the K+channel inhibitor 4-aminopyridine,” European Journal of Pharmacology 452 (2002), 325-337.
Thomas E. DeCoursey et al., “Voltage-gated K+channels in human T lymphocytes: a role in mitogenesis?,” Nature, vol. 307, Feb. 1984, pp. 465-468.
Margarita Garcia-Calvot et al., “Purification, Characterization, and Biosynthesis of Margatoxin, a Component ofCentruroides margaritatusVenom That Selectively Inhibits Voltage-dependent Potassium Channels,” The Journal of Biological Chemistry, vol. 268, No. 25, Issue of Sep. 5, pp. 18866-18874, 1993.
Eric N. Jacobsen, “Asymmetric Catalysis of Epoxide Ring-Opening Reactions,” Acc. Chem. Res. 2000, 33, pp. 421-431.
Jianlin Feng et al., “Antisense Oligodeoxynucleotides Directed Against Kv1.5 mRNA Specifically Inhibit Ultrarapid Delayed Rectifier K sup + Current in Cultured Adult Human Atrial Myocytes,” Ovid: Feng: Circ Res, vol. 80(4), Apr. 1997, pp. 572-579.
William Hu et al., “Depolarization-Induced86Rb30Efflux in CHO Cells Expressing a Recombinant Potassium Channel,” Journal of Pharmacological and Toxicological Methods 34, 1-7 (1995), pp. 1-7.
Paul M. Kerr et al., “Heteromultimeric Kv1.2-Kv1.5 Channels Underlie 4-Aminopyridine-Sensitive Delayed Rectifier K+Current of Rabbit Vascular Myocytes,” Circulation Research, Nov. 23, 2001, pp. 1038-1044.
Gloria C. Koo et al., “Blockade of the Voltage-Gated Potassium Channel Kv1.3 Inhibits Immune Responses in Vivo1,” Gloria C. Koo et al., The Journal of Immunology, pp. 5120-5128.
Gui-Rong Li, “Evidence for Two Components of Delayed Rectifier KplusCurrent in Human Ventricular Myocytes,” Ovid: Li: Circ Res, vol. 78(4), Apr. 1996, pp. 689-696.
Jaromir Plá{hacek over (s)}k et al., “Slow fluorescent indicators of membrane potential: a survey of different approaches to probe reponse analysis,” Journal of Photochemistry and Photobiology B: Biology 33 (1996) 101-124.
Dan M. Roden, MD, “Current Status of Class III Antiarrhythmic Drug Therapy,” The American Journal of Cardiology, vol. 72, Aug. 26, 1993, pp. 44B-49B.
Gemot Schram et al., “Differential Distribution of Cardiac Ion Channel Expression as a Basis for Regioanl Specialization in Electrical Function,” Circulation Research, May 17, 2002, pp. 939-950.
Dirk J. Snyders, “Structure and function of cardiac potassium channels,” Cardiovascular Research 42 (1999) 377-390.
Julius Gy. Papp et al., “Effect of Bertosamil on Atrial and Ventricular Threshold for Fibrillo-Flutter in Comparison with Quinidine in Anaesthetized Cats,” Pharmacological Research, vol. 25, Supplement 2, 1992, pp. 156-157.
Robert H. Spencer et al., “Immunological Indentification of theShaker-Related Kv1.3 Potassium Channel Protein in T and B Lymphocytes, and Detection of Related Porteins in Flies and Yeast,” Biochemical and Biophysical Research Communications, pp. 201-206.
L. Szekeres et al., “Mechanism of Increased Susceptibility to Fibrillation of the Hypothermic Mammalian Heart in Situ,” Brit. J. Pharmacol. (1961), 17, 167-175.
Schotten, U. et al., “Loss of atrial contractility is primary cause of atrial dilatation during first days of atrial fibrillation”, AJP-Heart Circ Physiol, vol. 287, Nov. 2004, pp. H2324-H2331.
Manning, W. J. et al., “Impaired Left Atrial Mechanical Function After Carioversion: Relation to the Duration of Atrial Fibrillation”, JACC, vol. 23, No. 7, Jun. 1994, pp. 1535-1540.
Boecker Christiane
Brueckner Reinhard
Fischer Yvan
Marrison Lester
Mlinaric Michael
Chandrakumar Nizal
Crowell & Moring LLP
Seaman D. Margaret
Solvay Pharmaceuticals GmbH
LandOfFree
Amidomethyl-substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amidomethyl-substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amidomethyl-substituted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2809049